HOME >> BIOLOGY >> NEWS
A killer microbe as a living antibiotic

Predatory bacteria are native to many microbial communities and have been found in terrestric and aquatic ecosystems, as well as in the human and animal intestine. A research team at the Max-Planck-Institute for Developmental Biology, together with their colleagues from the universities of Nottingham and Bielefeld has now unraveled for the first time the complete genome sequence of a predatory bacterium in order to identify molecular mechanisms that are important when bacteria hunt their own. Insights into this ancient dependency may give rise to novel anti-microbial substances. These substances, however, will not be based on the structures of today's chemical antibiotics, but rather will be deduced from the protein sequences that become available from the Bdellovibrio genome project. Furthermore, the scientists predict in their publication of this weeks edition of Science magazine that Bdellovibrio may be developed into a therapeutic agent that could be used as a "living antibiotic".

Bdellovibrio bacteriovorus is a fascinating predatory bacterium that attaches specifically to certain other bacteria in order to invade them. Once it has entered its prey, it begins to consume the host cell from the inside. Using Bdellovibrio's genomic information the life cycle of this unique bacterium can now be studied for the first time on a molecular level.

In the free-living phase of its life cycle Bdellovibrio swims at high speed while locating areas of high prey concentration by use of its chemosensory system. Once it has collided with a prey cell, Bdellovibrio stays reversibly attached to it while verifying its suitability for invasion. In the presented model, the recognition mechanism is likely to involve one of several pilus systems that produce long retractable fibers that allow Bdellovibrio to pull itself into close proximity with its prey. By using a lytic cocktail that is capable of degrading lipids, proteins and carbohydrate molecules,
'"/>

Contact: Priv.-Doz. Dr. Stephan C. Schuster
stephan.schuster@tuebingen.mpg.de
49-7071-601-440
Max-Planck-Gesellschaft
29-Jan-2004


Page: 1 2 3

Related biology news :

1. Molecular staples shape a cancer killer
2. Tracing a killers path in Lou Gehrigs disease
3. COPD is forgotten killer, says University of Toronto professor
4. Research into cetacean reproduction leads to birth of killer whales by artificial insemination
5. Frog skin and supercomputers lead Penn chemists to designing better bacteria killers
6. Male-killer bacteriums genome is deciphered
7. Natural killer cellers are made, not born
8. Elusive cancer killers deep-sea hideout discovered after a nearly 20-year hunt
9. Purdue works to transform Ebola virus from killer to healer
10. Popular weed killer feminizes native leopard frogs across Midwest
11. Researchers identify a gene essential for the natural killer cell response against cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: killer microbe living antibiotic

(Date:5/23/2013)... at Rollins School of Public Health at Emory ... of Technology, have received a $4 million grant ... at Emory University (Health and Exposome Research Center: ... exposome-based center grant awarded in the United States. ... the National Institute of Environmental Health Sciences (NIEHS) ...
(Date:5/23/2013)... Given the implications for the overall health, ... play a primary role in ensuring that all ... 60 minutes per day of vigorous or moderate-intensity ... Institute of Medicine. Recent estimates suggest that ... evidence-based guideline for promoting better health and development. ...
(Date:5/23/2013)... in treating cerebral palsy with autologous cord blood. Following ... year old boy had been in a persistent vegetative ... months after treatment with the cord blood containing stem ... the child learned to speak simple sentences and to ... study, dispel the long-held doubts about the effectiveness of ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2
(Date:5/23/2013)... , May 23, 2013 VG ... strategic alliance with DAK Renewable Research to conduct ... oil yield. VG Energy is a majority owned ... VGLS). VG Energy,s exclusively licensed compound ... the oil yield in plants, possessing a wide ...
(Date:5/23/2013)... 23, 2013 Virobay, Inc. today announced that ... reached an important milestone, as Virobay has now initiated ... selective cathepsin S inhibitor.   The first ... placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics ... adults. "The initiation of this Phase 1 ...
(Date:5/23/2013)... May 23, 2013 On April 19th ... to supermarkets to search for the growing antibiotic resistant ... Results from a year long study were released late ... foods, specifically meats, over previous years. For those suffering ... growth of antibiotic resistant bacteria in food, may eventually ...
(Date:5/23/2013)... Md. , May 23, 2013 Northwest ... biotechnology company developing DCVax ® personalized immune therapies ... use its exhibit at this year,s American Society Of ... to highlight its leadership role in immune therapy.  ... The ASCO annual meeting is the pre-eminent conference focused ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: